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Cancer cachexia is associated with a severe and often irreversible
loss of total body fat stores, which in mice has been shown to
occur before the onset of anorexia (Costa, 1963). This depletion of
host lipid stores may occur due to either a reduced rate of fatty acid
deposition or an increased rate of mobilization (Thompson et al,
1981). Rates of whole body lipolysis have been shown to be
greater in cachectic cancer patients with squamous cell carcinoma
of the oesophagus than in healthy controls (Klein and Wolfe,
1990), suggesting production by tumour or host tissues of regula-
tory molecules involved in fat catabolism. 
We have recently isolated a lipid-mobilizing factor (LMF) from
the urine of cachectic cancer patients and shown it to be homolo-
gous in amino acid sequence with the plasma protein Zn-α 2-
glycoprotein (Todorov et al, 1998). This material initiates lipolysis
through stimulation of adenylate cyclase in a GTP-dependent
process in a manner analogous to the lipolytic hormones (Hirai 
et al, 1998). The elevation of cyclic AMP would lead to an activa-
tion of hormone-sensitive lipase (HSL). Thompson et al (1993)
observed a 2-fold elevation in serum triacylglycerol and fatty acid
levels in cancer patients compared with normal controls, and a 
2-fold increase in the relative level of mRNA for HSL in adipose
tissue. There was no change in the relative level of the mRNA for
lipoprotein lipase (LPL), suggesting that an increased rate of
mobilization, rather than deposition, was most important for the
depletion of lipid stores. In addition the results suggest that the
increased lipolysis in adipose tissue in cachexia may be due to an
up-regulation of the lipolytic response in addition to the produc-
tion of lipolytic stimuli. 
The present report examines the sensitivity to lipolytic stimuli
of adipose tissue from mice bearing an experimental model of
cancer cachexia (MAC16), as well as alterations in adipocyte G-
protein expression during the development of cachexia, both in
mice and man, and the role of LMF in this process. 
MATERIALS AND METHODS 
Pure strain male NMRI mice (20–25 g) were obtained from our
own inbred colony, and fragments of the MAC16 adenocarcinoma
were implanted into the flanks by means of a trocar. Tumours were
removed when they weighed between 0.1 and 0.6 g and before
weight loss exceeded 20% of the total body weight. All animal
experiements meet UKCCCK guidelines and were approved by
the Home Office. Polyclonal antisera to Gα i (AS/7) and Gα s
(RM/1) were purchased from NEN Life Science Products, Boston,
MA, USA. Affinity purified rabbit anti-rat antibody to HSL was
kindly provided by Dr Cecilia Holm, Lund University, Sweden.
This antibody cross reacts with mouse HSL. Nitrocellulose
membranes were purchased from Hoefer Scientific Instuments,
San Francisco, CA, USA. Urine from cachectic cancer patients
was kindly provided by Dr A Moses, Department of Surgery,
Edinburgh Royal Infirmary, UK. 
Lipolytic assay 
A single cell suspension of white adipocytes were prepared from
finely minced epididymal fat pads of male NMRI mice bearing the
MAC16 tumour, using collagenase digestion (Beck and Tisdale,
1987). Samples to be assayed were incubated with 105–2 × 105
adipocytes (determined by means of a haemocytometer) for 2 h at
37˚C in 1 ml of Krebs-Ringer bicarbonate buffer, pH 7.2. The
concentration of glycerol released was determined enzymatically
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by the method of Wieland (1974). Control samples containing
adipocytes alone were analysed to determine the spontaneous
glycerol release. LMF was expressed as µ mol glycerol
released/105 adipocytes/2 h. 
Purification of LMF 
Material capable of inducing lipolysis in isolated murine
epididymal adipocytes was purified either from the solid MAC16
tumour or from the urine of cachectic cancer patients as previously
described (Todorov et al, 1998). The steps consisted of ion
exchange and exclusion chromatography followed by a Resource™
Iso hydrophobic interaction column to give an overall purification of
4200. This yielded a single protein of molecular weight 43 000 on
denaturing polyacrylamide gels (Todorov et al, 1998). 
Isolation of adipocyte plasma membranes 
The protocol was based on that previously described by Belsham
et al (1980). All procedures were carried out at 4˚C. Adipocytes
were homogenized in 10 mM Tris HCl, pH 7.4, containing
0.25 M sucrose and 2 mM EGTA, by aspirating through a Swinny
filter at least 10 times. The homogenate was then centrifuged at
300 g for 5 min. The supernatant was removed and centrifuged at 30
000 g for 1 h. Plasma membranes were separated from other
organelle membranes in the pellet on a self-forming Percoll
gradient. The constituents were 0.25 M sucrose, 2 mM EGTA in
10 mM Tris. HCl, pH 7.4, Percoll and 2 M sucrose, 8 mM EGTA
in 80 mM Tris. HCl, pH 7.4 mixed in a ratio of 32:7:1. The
mixture was centrifuged at 10 000 g for 30 min and the membrane
fractions were resuspended in 10 mM Tris. HCl, pH 7.4 containing
150 mM NaCl and 1 mM EGTA followed by centrifugation at 10
000 g for 2 min. The process was repeated twice. The washed
plasma membranes were diluted in 10 mM Tris. HCl, pH 7.4
containing 0.25 M sucrose, 2 mM EGTA and 4 µ M phenylmethyl-
sulfonyl fluoride at 1–2 mg ml–1 snap frozen in liquid nitrogen and
stored at –70˚C until use. 
Adenylate cyclase assay 
Adenylate cyclase activity in isolated plasma membranes was
determined using the method of Salomon et al (1974). The incuba-
tion mixture contained 25 mM Tris. HCl, pH 7.4, 5 mM MgCl2, 
10 µ M GTP, 8 mM creatine phosphate, 16 U ml–1 creatine phos-
phokinase, 1 mM 3-isobutyl-1-methylxanthine, 1 mM cyclic AMP
and 1 mM [α -32P] ATP (sp. act. 30 µ Ci mmol–1). The reaction was
initiated by the addition of plasma membranes (typically 50 µ g
protein) to the assay mixture to give a total volume of 100 µ l,
which was incubated at 30˚C for 10 min. Reactions were termi-
nated with 100 µ l 2% sodium dodecyl sulfate (SDS) containing 
40 mM ATP and 1.4 mM cyclic AMP. One microcurie of [3H]
cyclic AMP was added to each assay tube as an internal standard
to monitor product recovery. Samples containing labelled
nucleotides were diluted to 1 ml with water and loaded onto
Dowex 50W8-400 columns primed with 10 ml of water. After
washing twice with 1 ml of water the cyclic AMP was eluted with
3 ml of water into polypropylene tubes containing 200 µ l of 1.5 M
imidazole, pH 7.2. The samples were then applied to Alumina
WN-3 columns (previously washed with 8 ml of 0.1 M imidazole,
pH 7.5) and the eluate collected directly into scintillation vials
containing Optiphase HiSafe 3 scintillation fluid. A further 1 ml of
0.1 M imidazole was added to the columns and the eluate was
combined with the run through. The radioactivity was determined
using a Tri-carb 2000A scintillation analyser. 
Western blot analysis 
Samples of adipocyte plasma membrane (5 µ g for Gs and 50 µ g
for Gi) were resolved on 10% sodium dodecylsulfate polyacryl-
amide gels and transferred to 0.45 µ m nitrocellulose membranes,
which had been blocked with 5% Marvel in Tris buffered saline,
pH 7.5, at 4˚C overnight. The primary antibodies were used at a
1:2000 dilution, while the secondary antibody peroxidase conju-
gated monoclonal anti-rabbit immunoglobulin (Sigma Chemical
Co, Dorset, UK) was used at a dilution of 1:1000. Incubation was
for 2 h at room temperature and development was by enhanced
chemiluminescence (ECL) (Amersham, UK). Blots were scanned
by a densitometer to quantitate differences, and a parallel gel was
silver stained to ensure equal loading. All blots were repeated at
least 3 times on different incubations. 
3T3L1 maintenance and differentiation 
3T3 preadipocytes were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum under
an atmosphere of 10% CO2 in air. Cells were differentiated using a
mixture of methylisobutylxanthine (0.5 mM), dexamethasone
(0.25 µ M) and insulin (1 µ g ml–1) according to the method of Frost
and Lane (1985). The extent of differentiation to adipocytes was
determined by staining for fat globules using Oil Red O. Cells
were used for experimentation between 8 and 10 days after initia-
tion of differentiation. 
RESULTS 
Adipocytes isolated from the epididymal fat pads of male NMRI
mice bearing the MAC 16 tumour and with 15% weight loss
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Figure 1 Response of epididymal adipocytes from normal (hatched boxes)
and cachectic (15% weight loss) (stippled boxes) male NMRI mice to lipolytic
stimulation by isoprenaline and LMF. Basal lipolytic activity was not
significantly different between adipocytes isolated from normal and cachectic
mice (0.07 ± 0.004 and 0.057 ± 0.007 µ moles glycerol/105 adipocytes/2 h,
respectively). Basal activity has been substracted from each of the values
and the results are expressed as mean ± SEM where n = 6. Differences from
normal adipocytes were determined by Student’s t-test and are indicated as
a P ≤ 0.05 
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showed over a 3-fold increase in response to lipolytic stimula-
tion by both isoprenaline and LMF (Figure 1). The effect was more
marked with low concentrations of isoprenaline. Plasma
membranes prepared from adipocytes from mice bearing the MAC
16 tumour showed an enhanced stimulation of adenylate cyclase in
the presence of isoprenaline (Figure 2A) or LMF (Figure 2B)
when compared with adipocyte membranes from non-tumour
bearing mice. The effect on isoprenaline stimulation was marked
at submaximal concentrations (0.001 µ M), where little or no
response was observed in normal membranes, while there was no
difference in response between adipocyte membranes prepared
from cachectic and non-cachectic mice at optimal stimulatory
concentrations (Figure 2A). The difference between adipocyte
plasma membranes and intact cells may reflect differing GTP
requirements for the adipocytes from cachectic mice. The activity
of the LMF was potentiated in adipocyte membranes from
cachectic mice in a dose-dependent manner (Figure 2B). Up-
regulation of the response may be associated with the number or
activity of receptors, G proteins or the cyclase catalytic element.
The effect on the latter was determined by the use of forskolin,
which acts directly to stimulate adenylate cyclase. There was no
up-regulation of response to forskolin in adipocyte membranes
from cachectic mice (Figure 3), and there appeared to be greater
cyclic AMP production using plasma membranes from non-
cachectic animals. 
Immunoblotting of plasma membranes with the specific Gα s
antibody showed a marked increase in both 46 and 54 kDa Gα s
splice variants with increasing weight loss up to 10% (Figure 4A).
Thereafter, the levels of both variants decreased to that found in
mice with 5% weight loss, but were still significantly increased
above that found in mice with no weight loss. In contrast there was
a decrease in the intensity of the 40 kDa band detected with anti-
Gα i with increasing weight loss reaching a minimum at 10%
weight loss (Figure 4B) and thereafter increased with additional
host wasting. The ratio of Gα s to Gα i detected in adipocyte
plasma membranes increased markedly with increasing weight
loss (Table 1) reaching a maximum at 10% weight loss, whereafter
the value decreased, but still remained elevated over that found in
mice with no weight loss up to 15% weight loss. Treatment of
mice with EPA (0.5 g kg–1) which completely attenuated weight
loss (Beck et al, 1991) returned the Gα s/Gα i ratio back to control
levels (Table 1). 
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Figure 2 Formation of cyclic AMP by white adipocyte membrane
preparations (25 µ g/incubation) in response to isoprenaline (A) or LMF (B).
Adipocyte membranes were prepared from epididymal adipose tissue
isolated either from normal male NMRI mice (hatched boxes) or from NMRI
mice bearing the MAC16 tumour and with cachexia (15% weight loss)
(stippled boxes). Basal activity was subtracted from the values, which are
expressed as mean ± SEM, where n = 4 and represents 3 separate
experiments. Error bars smaller than the width of the symbols are not shown.
Differences from basal values were determined by Student’s t-test and are
indicated as A. P ≤ 0.05 and B. P ≤ 0.01 
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Figure 3 Forskolin (25 µ M) stimulation of adenylate cyclase in adipocyte
plasma membranes (30 µ g/incubation) isolated either from normal male
NMRI mice (hatched boxes) or from NMRI mice bearing the MAC16 tumour
and with cachexia (stippled boxes). Results are expressed as mean ± SEM
where n = 3 and differences from normal adipocytes as determined by
Student’s t-test are indicated as a. P ≤ 0.05 
Table 1 Gα s/Gα i ratio in adipocyte plasma membranes from mice bearing
the MAC 16 tumour or administered LMFa
Weight loss or treatment Gα s/Gα i 
0 0.83 
5 1.72 
10 3.14 
15 2.18 
20 0.73 
LMF 2.23 
MAC 16 + EPA 0.66 
aDetermined from densitometric analysis of the blot shown in Figure 4. 
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A similar change in G-protein expression was found in adipose
tissue of a patient with cancer cachexia, when compared with a
non-cachectic cancer patient, both with colonic cancer. Thus there
was an enhanced expression of Gα s in both omental and subcuta-
neous adipose tissue in the cachectic subject (Figure 5A), while
expression of Gα i was markedly reduced (Figure 5B). Thus the
Gα s/Gα i ratios were increased to a comparable extent as that
found in mice bearing the MAC16 tumour (Table 2). 
To determine if changes in G-protein expression in adipose
tissue were due to LMF ex-breeder male mice were injected 
i.v. with purified human LMF (8 µ g b.d. for 48 h). Plasma
membrances isolated from the epididymal fat pads of such animals
showed an increase in expression of Gα s, while Gα i remained
unchanged (Figure 4) raising the Gα s/Gα i ratio to levels found in
MAC16 mice with 15% weight loss (Table 1). Neither LMF (Hirai
et al, 1998) nor the MAC16 tumour (Beck and Tisdale, 1987)
induce anorexia, so the effect was not due to fasting. To investigate
whether this was a direct effect of LMF on G-protein expression
3T3L1 adipocytes were treated with increasing concentrations of
LMF from 12 to 580 nM for 24 h and plasma membranes 
were isolated and subjected to immunoblotting for Gα s and Gα i
(Figure 6). There was an increase in expression of Gα s with
increasing concentrations of LMF (Figure 6A), which was not
seen in 3T3L1 cells pretreated with 50 µ M EPA for 2 h prior to the
addition of LMF (Figure 6B). There was a decrease in Gα i expres-
sion with increasing concentrations of LMF with the maximum
decrease at 580 nM LMF (Figure 6C). In 3T3 cells pretreated with
50 µ M EPA there was no down-regulation of Gα i expression with
increasing concentrations of LMF (Figure 6D). The Gα s:Gα i 
Table 2 Gα s/Gα i ratio in subcutaneous (s.c.) and omental (om) adipocyte
plasma membranes from cachectic and non-cachectic subjectsa
Subject Gα s/Gα i 
Non-cachectic (s.c.) 0.32 
Cachectic (s.c.) 1.17 
Non-cachectic (om) 0.53 
Cachectic (om) 1.29 
aDetermined from densitometric analysis of the blot shown in Figure 5. 
Table 3 Gα s/Gα i ratio in adiopocyte membranes from 3T3L1 cells in the
absence (A) or presence (B) of 50 µ M EPA 
Gα s/Gα ia
Concentration of LMF (nM) A B 
0 1.00 1.00 
12 1.58 0.94 
58 1.46 0.94 
174 2.25 1.08 
406 2.85 1.23 
580 2.62 1.26 
aNormalized to control value of 1.00. 
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Figure 5 Immunodetection of Gα s (A) and Gα i (B) in subcutaneous (lanes
1 and 3) and omental (lanes 2 and 4) adipose tissue from a cancer patient
with no weight loss (lanes 1 and 2) and from a cachectic subject with 15%
weight loss (lanes 3 and 4) 
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12 3 4 56 7
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D
Figure 6 Immunodetection of Gα s (A and B) and Gα i (C and D) in 3T3L1
adipocytes incubated either alone (lane 1) or with 12 nM (lane 2); 58 nM
(lane 3); 174 nM (lane 4); 406 nM (lane 5) and 580 nM (lane 6) LMF for 24 h
in either the absence (A or C) or with a 2 h pretreatment with 50 µ M EPA 
(B and D) 
123 4 5 6 7
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B
Figure 4 Immunodetection of Gα s (A) and Gα i (B) in white adipocyte
plasma membranes isolated from mice bearing the MAC16 tumour with 0%
(lane 1), 5% (lane 2), 10% (lane 3), 15% (lane 4) and 20% (lane 5) weight
loss. Mice were also administered LMF (8 µ g b.d.) for 48 h which produced
7% weight loss and animals were terminated 12 h after the last injection and
adipocyte membranes were blotted for Gα s and Gα i (lane 6), while mice
bearing the MAC16 tumour were treated with EPA (0.5 g kg–1) (lane 7). Band
volume was measured as an indication of the quantity of G-protein present 
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ratio of cells treated with LMF with and without EPA is shown in
Table 3. Over 2-fold stimulation of Gα s:Gα i was seen at concen-
trations of LMF greater than 174 nM, while in cells pretreated with
EPA the Gα s:Gα i ratio remained near unity at all concentrations of
LMF. These results confirm the ability of LMF to directly alter
levels of expression of Gα s and Gα i and provide an explanation
for the inhibitory effect of EPA on this process. 
Low concentrations of LMF (12–58 nM) also caused an
increased expression of HSL in 3T3L1 adipocytes (Figure 7). Thus
LMF not only stimulates adenylate cyclase in adipocytes (Price
and Tisdale, 1998), but also modifies G-protein expression and
HSL to maximally activate lipolysis. 
DISCUSSION 
Both the induction of lipolysis and formation of cyclic AMP by
both isoprenaline and LMF have been shown to be up-regulated in
epididymal fat pads from cachectic mice bearing the MAC16
tumour compared with non-tumour-bearing mice. This suggests
that a feature common to the pathways of both agents has been up-
regulated. This appears not to be adenylate cyclase since forskolin,
which by-passes receptor binding and activates adenylate cyclase
directly, did not produce an enhanced response using adipocyte
membranes from cachectic animals. This suggests that the up-
regulated response in adipose tissue from cachectic animals is due
to modification of receptor number of guanine nucleotide-binding
protein (G-protein) expression. 
The G-proteins involved in the adenylate cyclase pathway
consist of Gs and Gi families that stimulate and inhibit adenylate
cyclase, respectively (Levitzki, 1987). Adipocyte plasma
membranes contain 2 Gs α -subunits and 2 Gi α -subunits, but not
Go (Hinsch et al, 1988). A number of stimuli control G-protein
expression in adipose tissue. Thus depletion of testosterone by
castration has been shown to induce a down-regulation of both
Gα s and Gα i 1 + 2, with testosterone replacement restoring Gα s
expression (Dieudonne et al, 1993). A concurrent up-regulation of
the expression of Gα i 1, Gα i 2 and Gα i 3, but not Gα s, has been
noted in adipocytes isolated from hypothyroid rats (Milligan 
and Saggerson, 1990), indicating an increased efficiency of
antilipolytic agents such as adenosine, and correlating with the
gain in body weight often observed in individuals exhibiting
hypothyroidism. Patients with Gs deficiency are obese and show a
decreased lipolytic response to adrenaline (Carel et al, 1999). In
addition heterologous desensitization of lipolysis appears at least
partly due to down-regulation of Gi (Green et al, 1992).
Stimulation of lipolysis by tumour necrosis factor-α (TNF-α )
appears to be by Gi protein down-regulation blunting endogenous
inhibition of lipolysis by adenosine (Gasic et al, 1999). Thus in
addition to agonist-mediated receptor expression, adipocyte
response to lipolytic stimuli also depends upon the expression and
conformation of G-proteins. 
To date there have been no measurements of G-protein expres-
sion in adipose tissue in cancer cachexia. This study reports
alterations in adipocyte G-proteins with the development of the
cachectic state in both mice bearing the cachexia-inducing MAC16
tumour and in a patient with cancer cachexia. The changes
consisted principally of a reduction in membrane Gα i expression
allied with increased expression of Gα s, changes which would
favour mobilization of lipid stores from adipocytes and hence
facilitate host tissue catabolism. Such alterations were observed in
mice manifesting up to 10–15% loss of their original body weight
and correlates with maximal production of LMF by the tumour
(Groundwater et al, 1990). 
Similar changes in G-protein expression were also seen in mice
administered LMF, as well as in 3T3L1 adipocytes in vitro,
showing that the observed changes in G-protein expression were a
direct effect of LMF. LMF was also found to stimulate expression
of HSL in 3T3 adipocytes, which may explain the increased levels
observed in adipose tissue of cancer patients (Thompson et al,
1993). 
The polyunsaturated fatty acid, eicosapentaenoic acid (EPA) has
been shown to attenuate the development of cachexia in both the
MAC16 model (Beck et al, 1991) and in patients with unresectable
pancreatic cancer (Wigmore et al, 1996), with preservation of
adipose stores. Using isolated white adipocytes we have previ-
ously shown EPA inhibition of both lipolysis and adenylate
cyclase stimulation by LMF to be a pertussis toxin-sensitive
process, suggesting the involvement of Gα i (Price and Tisdale,
1998). The effect appears to arise from a direct attenuation of the
action of LMF on G-protein expression in adipose tissue, resulting
in an increased Gα i/Gα s expression. 
Thus tumours secreting LMF will maximize catabolism of
adipose tissue by the continuous production of this lipolytic stim-
ulus, together with increases in Gα s/Gα i and HSL, which will
sensitize the adipocytes to a range of lipolytic stimuli. Such
changes would explain the 85% fall in total body fat reported for
lung cancer patients who had lost 30% of their pre-illness stable
weight (Fearon, 1992) if energy utilization was also increased. In
mice administered LMF a 3-fold increase in oxygen consumption
by interscapular brown adipose tissue was observed (Hirai et al,
1998) suggesting an increase in thermogenesis. The mechanism by
which this occurs will be the subject of further investigation. 
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